Incident fractures in HIV-infected individuals: a systematic review and meta-analysis.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMC 4030545)

Published in AIDS on July 31, 2013

Authors

Stephanie Shiau1, Emily C Broun, Stephen M Arpadi, Michael T Yin

Author Affiliations

1: aGertrude H. Sergievsky Center bDepartment of Epidemiology, Mailman School of Public Health cDepartment of Medicine, Division of Infectious Disease dDepartment of Pediatrics, Columbia University Medical Center, New York, New York, USA.

Articles citing this

Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis. AIDS (2014) 1.00

Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis (2015) 0.99

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 0.91

Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS (2014) 0.90

Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study. AIDS (2014) 0.87

Management of endocrine disease: Secondary osteoporosis: pathophysiology and management. Eur J Endocrinol (2015) 0.83

Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res (2016) 0.83

Efavirenz is associated with higher bone mass in South African children with HIV. AIDS (2016) 0.82

Bone Density and Fractures in HIV-infected Postmenopausal Women: A Systematic Review. J Assoc Nurses AIDS Care (2015) 0.81

Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals. J Infect Dis (2016) 0.80

Substance use in older HIV-infected patients. Curr Opin HIV AIDS (2014) 0.79

Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks. AIDS (2015) 0.79

Vitamin D and bone loss in HIV. Curr Opin HIV AIDS (2016) 0.78

The effect of HIV-hepatitis C co-infection on bone mineral density and fracture: a meta-analysis. PLoS One (2014) 0.78

Tenofovir and bone health. Curr Opin HIV AIDS (2016) 0.78

Bone loss in HIV: a contemporary review. Curr Opin Endocrinol Diabetes Obes (2015) 0.77

HIV infection and osteoporosis. Bonekey Rep (2015) 0.77

Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans. PLoS One (2015) 0.77

Fractures Are Not Associated with CD8(+) T Cell Activation: An Analysis of the ACTG ALLRT Study. AIDS Res Hum Retroviruses (2015) 0.76

Fall frequency and associated factors among men and women with or at risk for HIV infection. HIV Med (2016) 0.76

Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens. PLoS One (2016) 0.75

Osteoporosis in postmenopausal women living with HIV. Maturitas (2016) 0.75

Bone health in HIV-infected children, adolescents and young adults: a systematic review. J AIDS Clin Res (2014) 0.75

Bone health in HIV and hepatitis B or C infections. Ther Adv Musculoskelet Dis (2016) 0.75

The effect of HIV infection on the incidence and severity of circular external fixator pin track sepsis: a retrospective comparative study of 229 patients. Strategies Trauma Limb Reconstr (2014) 0.75

Perspectives on menopause and women with HIV. Int J Womens Health (2016) 0.75

Does systemic inflammation and immune activation contribute to fracture risk in HIV? Curr Opin HIV AIDS (2016) 0.75

Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients. AIDS Res Hum Retroviruses (2015) 0.75

An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS). AIDS (2017) 0.75

Articles cited by this

CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS (2006) 5.58

Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis (2011) 4.79

Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis (2011) 4.31

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab (2008) 3.64

Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol (2009) 3.05

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr (2009) 2.75

HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci (2007) 2.75

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One (2011) 2.11

Development and use of FRAX in osteoporosis. Osteoporos Int (2010) 2.04

Continuous antiretroviral therapy decreases bone mineral density. AIDS (2009) 1.96

Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95

Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS (2012) 1.90

Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis (2011) 1.83

Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr (2009) 1.69

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults. AIDS (2009) 1.46

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. J Clin Invest (2004) 1.45

Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. AIDS (2012) 1.45

CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab (2007) 1.42

Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045. AIDS (2010) 1.35

Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients. J Acquir Immune Defic Syndr (2011) 1.24

Fractures after antiretroviral initiation. AIDS (2012) 1.21

HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Arch Virol (2004) 1.19

Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study. AIDS (2010) 1.19

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology (2012) 1.16

Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS (2009) 1.04

Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B. Clin Infect Dis (2012) 1.02

HIV protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in primary human osteoblasts. AIDS Res Hum Retroviruses (2007) 0.99

HIV type 1 alters mesenchymal stem cell differentiation potential and cell phenotype ex vivo. AIDS Res Hum Retroviruses (2010) 0.89

Hip bone geometry in HIV/HCV-co-infected men and healthy controls. Osteoporos Int (2011) 0.83

Articles by these authors

Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis (2010) 2.20

Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One (2011) 2.11

Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy. J Infect (2012) 1.28

Physiologic frailty and fragility fracture in HIV-infected male veterans. Clin Infect Dis (2013) 1.26

Bioelectrical impedance analysis models for prediction of total body water and fat-free mass in healthy and HIV-infected children and adolescents. Am J Clin Nutr (2002) 1.18

Low bone mineral density, HIV infection, and women: fracture or fiction? Clin Infect Dis (2006) 1.07

Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol (2011) 1.05

Failure to test children of HIV-infected mothers in South Africa: implications for HIV testing strategies for preschool children. Trop Med Int Health (2011) 1.04

Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis. AIDS (2014) 1.00

Klebsiella pneumoniae K1 liver abscess and septic endophthalmitis in a U.S. resident. J Clin Microbiol (2013) 0.96

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial. Ann Intern Med (2015) 0.95

Dental students and bloodborne pathogens: occupational exposures, knowledge, and attitudes. J Dent Educ (2012) 0.94

Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2015) 0.94

The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations. Curr Infect Dis Rep (2011) 0.94

Lactation-associated postpartum weight changes among HIV-infected women in Zambia. Int J Epidemiol (2010) 0.91

Association of regional body composition with bone mineral density in HIV-infected and HIV-uninfected women: women's interagency HIV study. J Acquir Immune Defic Syndr (2012) 0.90

Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS (2014) 0.90

The association of HIV status with bacterial vaginosis and vitamin D in the United States. J Womens Health (Larchmt) (2011) 0.88

Compliance with referrals for non-acute child health conditions: evidence from the longitudinal ASENZE study in KwaZulu Natal, South Africa. BMC Health Serv Res (2014) 0.88

Five cases of bacteraemia due to Gordonia species. J Med Microbiol (2009) 0.87

Survey of HIV care providers on management of HIV serodiscordant couples - assessment of attitudes, knowledge, and practices. AIDS Care (2014) 0.86

Rates and determinants of ventriculostomy-related infections during a hospital transition to use of antibiotic-coated external ventricular drains. Neurosurg Focus (2013) 0.84

Increasing clarity on bone loss associated with antiretroviral initiation. J Infect Dis (2011) 0.83

Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks. AIDS Patient Care STDS (2011) 0.82

Efavirenz is associated with higher bone mass in South African children with HIV. AIDS (2016) 0.82

Bone Density and Fractures in HIV-infected Postmenopausal Women: A Systematic Review. J Assoc Nurses AIDS Care (2015) 0.81

Long-term body composition changes in antiretroviral-treated HIV-infected individuals. AIDS (2016) 0.80

"Against Medical Advice" Discharges Among HIV-Infected Patients: Health and Health Services Outcomes. J Assoc Nurses AIDS Care (2016) 0.77

Pediatric treatment 2.0: ensuring a holistic response to caring for HIV-exposed and infected children. AIDS (2013) 0.76

Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants. AIDS (2016) 0.75

Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected Women. J Acquir Immune Defic Syndr (2016) 0.75

High performance liquid chromatography-mass spectrometry assay for polymyxin B1 and B2 in human plasma. Ther Drug Monit (2012) 0.75

Editorial comment: wanted--noninvasive interventions for lipodystrophy in HIV-infected children. AIDS Read (2007) 0.75

Longitudinal increase in vitamin D binding protein levels after initiation of tenofovir/lamivudine/efavirenz among individuals with HIV. AIDS (2016) 0.75

Associations of Education Level and Bone Density Tests among Cognitively Intact Elderly White Women in Managed Medicare. Curr Gerontol Geriatr Res (2012) 0.75

HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer. J Acquir Immune Defic Syndr (2017) 0.75

Dietary Inadequacies in HIV-infected and Uninfected School-aged Children in Johannesburg, South Africa. J Pediatr Gastroenterol Nutr (2017) 0.75

Using Clinical Notes and Natural Language Processing for Automated HIV Risk Assessment. J Acquir Immune Defic Syndr (2017) 0.75

Rationale and design of a study using a standardized locally procured macronutrient supplement as adjunctive therapy to HIV treatment in Kenya. AIDS Care (2013) 0.75